David Horowitz Appointed Assistant Commissioner for Policy
The FDA has appointed David Horowitz as the assistant commissioner for policy.
The FDA has appointed David Horowitz as the assistant commissioner for policy. Since 2005, Horowitz served as the assistant commissioner for compliance policy in the Office of Regulatory Affairs (ORA). He also played a leading role in constructing and beginning implementation of FDA’s Import Strategy that gave rise to the Action Plan for Import Safety developed by the President’s Interagency Working Group on Import Safety. Since joining the FDA in 1991, Horowitz has also served as associate chief counsel for enforcement, associate chief counsel for drugs, and director of the Office of Compliance in the Center for Drug Evaluation and Research.
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.
